Bellus Health cuts 45% of workforceBellus Health delists from Nasdaq
Homotaurine (3-amino-1-propanesulfonic acid - aka : 3aps) is being developed by Bellus Health Inc. for the treatment of Alzheimer's disease. It is currently being marketed as an agent which can protect memory function "Vivimind". Homotaurine is a synthetic gamma-aminobutyric acid (GABA) analog that functions as an agonist at the GABA-A receptor and has been discovered to bind to amyloid beta.
Alzheimer's Disease Education and Referral Center NLM (Pubmed) search results for 'homotaurine' and '3aps' Clinicaltrials.gov search results for 'homotaurine' and '3aps' Big Pharmaceutical Companies - caveat emptor!
|